Clinical Trial Update: Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating long-term voclosporin for lupus nephritis in adolescents and pediatric patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• LUPKYNIS (voclosporin)

Snippet

Sponsor: Aurinia Pharmaceuticals Inc. | Conditions: Adolescent Lupus Nephritis, Pediatric Lupus Nephritis | Phase 3 | Status: TERMINATED